GOLDENWELL BIOTECH, INC. (GWLL) Net margin 2021–2025
GOLDENWELL BIOTECH, INC. (GWLL) net profit margin by fiscal year — reported net income divided by reported revenue.
-539038.2%FY2025 · since FY2021: -732.6% → -539038.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -539038.2% | -444435.3 pp |
| FY2024 | -94602.9% | -89587.5 pp |
| FY2023 | -5015.4% | -2954.6 pp |
| FY2022 | -2060.9% | -1328.2 pp |
| FY2021 | -732.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice